Feature

Breast cancer mortality mapped for 2017


 

U.S. breast cancer mortality will be an estimated 25.3 per 100,000 females in 2017, with the highest state rates in the East and the lowest in the West and Midwest.

Approximately 40,600 breast cancer deaths are predicted for the year in the United States by the American Cancer Society in its Cancer Facts & Figures 2017, based on 2000-2014 data from the National Center for Health Statistics. With the U.S. population currently around 321 million, that works out to a completely unadjusted death rate of 25.3 per 100,000 women. Doing a little more math puts the highest death rate (29.8) in West Virginia and the lowest (18.8) in Utah.

The incidence rate for female breast cancer was 123.3 per 100,000 for 2009-2013, with that figure age adjusted to the 2000 U.S. standard population, according to data from the North American Association of Central Cancer Registries, the ACS reported.

Wyoming had the lowest incidence over that time period (109.6 per 100,000), and New Hampshire had the highest at 138.1. Utah had the fifth-lowest incidence in that period at 112.7, but West Virginia, the state with the highest estimated mortality for 2017, had a relatively low incidence of 114.4 in 2009-2013, the ACS said.

Estimated colon and rectum cancer death rates for 2017
rfranki@frontlinemedcom.com

Recommended Reading

Left ventricle dose predicts heart events after BC radiation
MDedge Hematology and Oncology
Residual disease burden is prognostic across breast cancer phenotypes
MDedge Hematology and Oncology
Axial radiotherapy noninferior to cALND in early invasive breast cancer
MDedge Hematology and Oncology
Survival better with breast-conserving therapy for early cancers
MDedge Hematology and Oncology
START again shows safety of hypofractionated doses in early breast cancer
MDedge Hematology and Oncology
Optimal adjuvant endocrine therapy use in breast cancer remains elusive
MDedge Hematology and Oncology
Lipid-lowering meds benefit some breast cancer patients
MDedge Hematology and Oncology
Scalp cooling reduces hair loss in 50% or more of women in separate studies
MDedge Hematology and Oncology
Oral contraceptive use confers long-term cancer protection
MDedge Hematology and Oncology
‘Strong evidence’ links obesity to cancers
MDedge Hematology and Oncology